VP Discovery Technology
BenevolentAI
London, England, United Kingdom
Dr James Dunbar is VP of Discovery Technology at BenevolentAI where he leads teams to build and maintain platform capabilities that allow drug discovery scientists to use the Benevolent Platform™'s integrated multimodal biomedical data to improve their decision making and build the Company’s portfolio of drug programmes. His team maintains a high standard of scientific and technical quality in the Benevolent Platform™'s tools and machine learning models that are used to explore and uncover disease biology, prioritise and assess potential novel drug targets, and design small molecule candidates for in-house projects and external collaborations.
Disclosure information not submitted.
Putting large language models into action for target Identification
Tuesday, May 28, 2024
15:00 – 15:30 CEST